Aethlon Medical Net Worth 2010-2024 | AEMD

Interactive chart of historical net worth (market cap) for Aethlon Medical (AEMD) over the last 10 years. How much a company is worth is typically represented by its market capitalization, or the current stock price multiplied by the number of shares outstanding. Aethlon Medical net worth as of November 22, 2024 is $0.01B.
Sector Industry Market Cap Revenue
Medical Medical - Health Maintenance Organizations $0.005B $0.001B
Aethlon Medical, Inc. is a development stage medical device company focused on expanding the applications of our Hemopurifier (R) platform technology, which is designed to rapidly reduce the presence of infectious viruses and other toxins from human blood. In this regard, its core focus is the development of therapeutic devices that treat acute viral conditions, chronic viral diseases and pathogens targeted as potential biological warfare agents. The Hemopurifier(R) combines the established scientific principles of affinity chromatography and hemodialysis as a means to mimic the immune system's response of clearing viruses and toxins from the blood before cell and organ infection can occur. The Hemopurifier(R) cannot cure viral conditions but can prevent virus and toxins from infecting unaffected tissues and cells. The company has completed pre-clinical blood testing of the Hemopurifier(R) to treat HIV and Hepatitis-C, and have completed human safety trials on Hepatitis-C infected patients in India.
Stock Name Country Market Cap PE Ratio
UnitedHealth Group (UNH) United States $549.861B 22.11
Cigna Group (CI) United States $91.810B 12.01
Humana (HUM) United States $35.607B 16.21
Centene (CNC) United States $30.469B 8.94
Molina Healthcare (MOH) United States $16.935B 13.47
Select Medical Holdings (SEM) United States $5.058B 17.52
Joint (JYNT) United States $0.173B 105.18